2021 Bipolar disorder Pharmaceuticals 
Mad in America
MARCH 15, 2025
This turn to ketamine is occurring despite the fact that the Food and Drug Administration has repeatedly warned that the FDA has not approved ketamine for the treatment of any psychiatric disorder (though controversially approving esketamine nasal spray). accepting personal or office gifts or corporate donations from industry.
Mad in America
OCTOBER 10, 2023
With the explosion of more and more drugs in cabinets across the country, more and more children are dying—but still, pharmaceutical companies push their products, leading to yet more drugs and yet more deaths. Unlike the pharmaceutical industry, in our village community the pain of losing a single child was felt by all.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
JANUARY 9, 2025
But now they often say Since they have bipolar disorder, theyll never be able to manage their emotions or achieve any stability. Whitaker, R Anatomy of an Industry: Commerce, Payments to Psychiatrists and Betrayal of the Public Good Madinamerica.com, Sep 18, 2021. Silverman, E What money? 2008 Sep 25;2;26.
Mad in America
NOVEMBER 6, 2023
As Whitaker noted, the research literature shows that psychosis pills and depression pills increase the chronicity of the disorders, and the same is true for stimulants, benzodiazepines, and drugs used for bipolar disorder. 650 None of this history is found in Insel’s book or on NIMH’s website. They used the UFO trick.
Mad in America
OCTOBER 21, 2023
In 2021, New York Times reporter Benedict Carey, after covering psychiatry for twenty years, concluded that psychiatry had done “little to improve the lives of the millions of people living with persistent mental distress. Mainstream media is another major player in the psychiatric-pharmaceutical-industrial complex.
Expert insights. Personalized for you.
103 
Let's personalize your content